Introduction
Isolated deficiency of a single anterior pituitary hormone without ascertainable disease of the pituitary gland or hypothalamus is known to clinical endocrinologists, even if uncommon. The pathogenesis is obscure. Probably the commonest defect is isolated gonadotrophin deficiency, usually causing failure to enter puberty (Odell 1966) ; when associated with anosmia, and familial (Kallman et al. 1944 ,Santen & Paulsen 1973 ,it is often attributed to a 'mid-line defect of brain development' or other hereditary cause -as also in the Lawrence-Moon Biedl syndrome, or in Friedreich's ataxia. Isolated growth hormone deficiency without apparent cause also usually becomes evident in childhood, as growth failure, and so may be a developmental or inherited defect.
However, isolated adrenal corticotropic hormone (ACTH) or thyroid-stimulating hormone (TSH) deficiency is usually discovered in subjects over 40 years of age (Odell 1966) . In such patients it is hard to imagine that the defect is a developmental one, and there is little published data indicating whether the cause is primarily in the pituitary or in hypothalamic releasing hormone mechanisms. Autoimmune pituitary failure seems possible. Reported here are 2 cases which have been fully investigated, including autoimmunity studies and the use of extrasensitive cytochemical assays capable of measuring changes in the subnormal levels of ACTH or TSH present. The results, together with those of previous cases, are compatible with an acquired defect in the pituitary itself, but this is not clearly defined.
Methods
Plasma ACTH was assayed by N-terminal and C-terminal-specific radioimmunoassay (Rees et al. 1971 )and by cytochemical bioassay (Chayen et al. 1972) . N-beta-lipotropin hormone (N-f1-LPH) was measured by radioimmunoassay. Serum TSH was measured by standard doubleantibody radioimmunoassay using as standard methylrosaniline chloride (MRC) 68/38, and for iodination, human pituitary TSH kindly supplied by Dr A Stockell Hartree. Assays were made using two antisera kindly supplied by the National Institutes of Health (Bethesda, Maryland) and by Dr W R Butt (Queen Elizabeth Hospital, Birmingham), and also in case 2 by cytochemical bioassay (Bitensky et al. 1974) . Plasma cortisol was measured by competitive protein binding assay (Murphy 1967) modified by the use of Sephadex instead of Florisil. Serum prolactin was measured by radioimmunoassay.
Follicle-stimulating hormone (FSH), luteinizing hormone (LH) and growth hormone (GH) assays were those of Marshall et al. (1973 Marshall et al. ( , 1972 and Hartog et al. (1964) respectively. Pituitary fossa volumes were measured by the method of Lusted & Keats (1967) . Gonadotrophinreleasing hormone (LHRH) was purchased from Ayerst and TRH was kindly given by Roche Laboratories.
Patients and results
Case 1: ACTH deficiency An unmarried woman, aged 51, developed amenorrhoea and typical menopausal hot flushes, for which she was prescribed Premarin (conjugated equine oestrogens). After two weeks, she experienced matutinal nausea and vomiting and over the next two months her weight fell from a slightly obese 83 kg to 70 kg. She complained of fatigue and some anorexia. The oestrogens were withdrawn and the vomiting diminished, but she continued to lose weight. Lying blood pressure was 140/100. After a further six months her weight had reached 56 kg and she underwent extensive gastrointestinal investigation, but a random sample submitted for cortisol assay showed undetectable levels. Plasma cortisol was still low (90 nmol/l) at 45 minutes after intramuscular injection of tetracosactrin (0.25 mg) and she was treated with dexamethasone 0.25 mg twice daily (pending further investigation) with immediate and complete relief of all symptoms, except the amenorrhoea and hot flushes. She was given intramuscular injections of tetracosactrin zinc (1 mg) at intervals of 48 hours; plasma cortisol concentration, undetectable before the first injection, rose progressively to reach a maximum of 1005 nmol/l 24 hours after the second injection. Steroids were withdrawn for 5 days and she was readmitted to hospital for further tests. Blood pressures were then: lying, 160/95; standing, 130/90. Careful study of pituitary fossa X-rays, including tomography, showed no abnormality, and the estimated fossa volume was 743 mrrr', Serum thyroxine was 110 nmol/l (normal, 50-140), and plasma oestradiol was also normal at 395 pmol/l. The results of combined administration of insulin (0.15 units/kg), LHRH (100 ug) and thyrotropin-releasing hormone (TRH) (200 Ilg) intravenously are shown in Table 1 (a). She was subsequently treated with prednisolone 2.5 mg three times daily, but her blood pressure rose to 200/110; the dose was reduced to 2.5 mg twice daily, although this resulted in some loss ofenergy. Steroids were again withdrawn two months later for 48 hours and the insulin hypoglycaemia test repeated, together with TRH stimulation of prolactin, with the results shown in Table 1 (b) . Obvious neuroglycopaenic symptoms were present from 60 to 100 minutes after the injection. Since the basal prolactin was elevated and the response to TRH exaggerated, the TRH test alone was repeated when she had been reestablished on replacement therapy with prednisolone, this time with normal results (Table 1 (cj). Premarin was reintroduced for the menopausal symptoms. Finally, steroids were again withdrawn for 48 hours and 10 iu of lysine vasopressin (Syntopressin) was injected intramuscularly. Samples were withdrawn for ACTH at 0,30 and 60 minutes, with the results shown in Table 1 (d). The injection produced considerable pallor, but only a transient rise in blood pressure to 190/100.
The patient remains we1122 months after initial presentation and there has been no change in the pituitary fossa on X-ray. Her serum has been examined for endocrine autoantibodies (Table 2) .
Case 2: TSH deficiency
A man of 55 years, with 2 children, was referred to hospital for deafness. Audiometry showed this to be of sensorineural type, but his physical appearance was thought to be rather suggestive of acromegaly. Thorough enquiry elicited no other symptoms, and abnormal signs amounted to some facial coarsening and thickening of the fingers, with increased skin thickness (by calipers) at 3.5--4.0 mm. However, growth hormone levels during 21 hours after a standard oral 50 g glucose load were undetectable, although the glucose curve showed chemical diabetes (fasting 5.8 nmol/l; 120 min value 8.4 nmol/l). Somatomedin A (chick cartilage assay) was normal at 1.04 and 1.3 units (Ashton & Francis 1977) . Total serum T4 (32 and 29 nmol/l), free T4 Index (39) and total serum T3 (1.2 and 1.1 nmol/!) were subnormal. Meantime a combined pituitary stimulation test by intravenous injection of 0.3 units/kg insulin, 100llg LHRH (resulting in profound hypoglycaemia) produced normal GH, cortisol, and LH responses ( Table 3) . The basal TSH level was not raised, however, and the response to TRH was subnormal ( Figure I ) on three occasions, although the prolactin response to TRH was normal. Moreover, immunoreactive serum TSH did not rise significantly during 22 days of oral administration of 40 mg of TRH (Roche) twice daily (samples were taken 2-4 hours after the morning dose ofTRH). There was a small rise in TSH measured by cytochemical assay (Table  4 ). Careful examination of pituitary fossa X-rays showed no abnormality (volume 693 mm '). The patienthas since been treated with 0.2 mg ofL-T4 daily, but still does not admit to any initial symptoms. However, his T4 (57 nmol/l) and T3 (1.35) remain low, with a Thyopac-3 of 70. He remains well 12 months after initial diagnosis, and there has been no change in pituitary fossa radiology. Tests of his serum for endocrine autoantibodies are shown in Table 2 . The low Thyopac-3 results suggest thyroxine binding globulin (TBG) or thyroxine binding prealbumin (TBPA) deficiency; serum TBG concentration was low (4.4 mg/l, normal 6-16) when measured by monorocket electrophoresis, but TBPA was normal at 295 ng/l. 
Discussion
Isolated A CTH deficiency This appears to be very rare. Odell (1966) reviewed 10 cases published to that date, in whom despite lack of ACTH assays at that time, the diagnosis seems certain. A further 12 cases, making 22 in all, are reviewed by Limjuco et al. (1976) , and further cases by Kratz & Graef (1973) , Satlerfield & Williamson (1976), Aynsley-Green et al. (1977) , Aubert et al. (1976) (2 cases), Yamamoto et at. (1976) and Baba et al. (1976) . These, together with the present case, represent a total of 31 reported patients, of whom 17 were over 40 years of age, and only 5 were children. The condition is reported twice as often in males as in females. Presentation has usually been with either general hypoadrenal symptoms, as in our case, or as spontaneous or ethanol-induced hypoglycaemia, as in over a third of the cases.
Hung & Migeon (1968) described a two-year-old boy who presented with hypoglycaemia. In addition to tests carried out in the previously reported cases, a low level of ACTH was shown by radioimmunoassay, and adrenal medullary insufficiency was shown. Aldosterone was normal. This case closely resembles that reported, also from Oxford, by Aynsley-Green et al. (1977) in a 7 year old, and well documented by ACTH and other assays. Finally, a short report of 3 children (age not given) with hypoglycaemia and apparent ACTH deficiency was published by Martin & Martin (1971) . The hypoglycaemia, when present, may be precipitated by adrenal medullary insufficiency consequent upon deficient cortisol supply to the medulla (Hung & Migeon 1968 ). However, ethanol-induced hypoglycaemia may produce subnormal GH responses compared to insulin hypoglycaemia (Arky & Freinkel 1964 , Abramson & Arky 1968 in patients with ACTH deficiency, thus accentuating the tendency to hypoglycaemia in some patients. This may account for the frequency of alcoholism found among patients with apparent isolated ACTH deficiency (Steer et al. 1969) . Drinking alcoholics have a sluggish or absent pituitary-adrenal response to insulin hypoglycaemia in any event (Marks 1975) . Thus, alcoholism should always be sought in cases of isolated ACTH deficiency. In our patient alcohol was not a factor as far as we could ascertain.
In most cases, the pathogenesis of the condition is obscure. Martin & Martin's (1971) three cases were reported to show a response of ACTH to lysine vasopressin injection (although details are not given), and our case showed a subnormal response of ACTH to insulin hypoglycaemia which was only detectable by cytochemical assay because of the low concentrations. She, however, showed no acute response to lysine vasopressin, though prolonged administration, if it were practical, might have been more informative. It is thus not possible to define the defect as either due to pituitary corticotroph insufficiency or failure of hypothalamic corticotropin-releasing factor (CRF) mechanisms, nor even to indicate that all cases have the same pathogenesis.
An acquired defect of CRF is hard to envisage. The presence of marked pigmentation in 5 previously reported cases (see Limjuco et al. 1976 ) might suggest an abnormality in the pituitary control oflipotrophin and ACTH release. However, this feature is not constant, and so the pathogenesis may vary. The pathology is known only from the reports of Perkoff et al. (1960) and Odell et al. (1960) . The only abnormality found (and this only in PerkofT'scase) was a reduced number of pituitary basophilic staining cells; this feature could not be assessed in Odell's case, though the pituitary was of normal weight. We suggest that careful study of pituitary basophils by immunofluorescence and electron microscopy of ACTH secretory granules would be desirable in any necropsy carried out in a patient with this condition.
The study of pituitary autoimmunity is still in its infancy. Pituitaries show nonspecific immunofluorescence of corticotrophs with even normal sera (Pouplard et al. 1976) , and at present firm conclusions about the presence or absence in our case of autoantibodies directed against the corticotroph cannot be drawn. There is little evidence so far of pituitary failure associated with pituitary autoantibodies (Bottazzo & Doniach 1978 , Bottazzo et al. 1975 .
The hyperprolactinaemia in our patient, present during steroid insufficiency but not when on replacement treatment, has been reported in Addison's disease (RefetofT et al. 1972) . Its presence in our patient is clearly not associated with elevated ACTH levels, and so may be due to cortisol insufficiency per se.
TSH deficiency
Our case resembled the 16 previously reviewed by Odell (1966) in that hypothyroidism was not obvious nor symptomatic. Presumably, as in our case, the deficiency may not be complete. This is, however, not invariably so (Shuman 1953 , Sawin & McHugh 1966 , Lange & Donker 1967 , Gupta et al. 1971 . In those cases, TSH data was not available and the diagnosis rested on showing hypothyroidism which responded to exogenous TSH. Subsequent reports (Miyai et al. 1971 , Sato et al. 1975 , Sachson et al. 1972 , Zisman et al. 1969 have included demonstration of subnormal or normal serum TSH concentrations which did not respond acutely to TRH, though some of these were childhood cases unlike those reviewed by Odell. Such short-term absences of response to TRH do not necessarily prove either TSH deficiency or a pituitary defect, because the TSH response to TRH is reduced or abolished by corticosteroids (Otsuki et al. 1973 , Re et al. 1976 ) and in the elderly (Wagner et al. 1975 , Burrows et al. 1977 , as well as in acromegaly and diabetes (Berthezene et al. 1976) . Moreover, small increments of TSH in response to TRH have been shown in this condition if sufficiently sensitive methods are employed, as in our case and that of Boehm et al. (1976) . The case described by Kruskemper et al. (1973) with a normal response ofTSH to TRH seems doubtful.
Our case (like those of Miyai et al. 1974 Miyai et al. , 1977 showed resistance to prolonged TSH stimulation by continuous TRH administration for 23 days. This might suggest that the defect is pituitary rather than hypothalamic, since no other factors known to inhibit TRH responsiveness were present. Aberrant GH responses to TRH (Miyai et al. 1977 ) may be present in such patients, though in these cases as in ours the prolactin response to TRH was normal, as found also by Sachson et al. (1972) . These findings are compatible with an inborn or acquired defect in the thyrotrophs. The explanation for the familial type (Miyai et al. 1971 ) is obscure. Disorders reported in association with TSH deficiency include Klinefelter's syndrome (10 cases, not detailed: Pousset et al. 1974) ; pseudohypoparathyroidism (Zisman et al. 1969 , Winnacker et al. 1966 ); Albright's disease (Aubert & Arroyo 1968) ; and an obscure neuropathy (Grabow & Chon 1968 ).
Failure of serum. from Case 2 to show abnormal immunofluorescence with pituitary thyrotrophs mirrors the lack of apparent autoimmunity in other cases of TSH deficiency (Bottazzo & Doniach 1978) and we draw no firm conclusions from this negative result. His TBG deficiency is interesting in view of the TSH dependence of binding glycoprotein concentration in rats (Westphal 1970) , although previous reports of TSH-deficient patients do not suggest that that is a usual phenomenon.
Summary
A case of isolated ACTH deficiency presenting at age 51 and another of isolated TSH deficiency presenting at age 55 have been studied. Pituitary radiology was unequivocally normal in both patients. The patient with ACTH deficiency had a partial defect, subnormal levels of ACTH measured by cytochemical bioassay being detectable basally and increasing slightly after insulin hypoglycaemia (though undetectable by both N-terminal and C-terminal radioimmunoassay under all conditions). There was no ACTH response (measured by cytochemical bioassay) to lysine vasopressin. The adrenal response to exogenous 1-24 corticotrophin was normal (though delayed) and gonadotrophins were normal (menopausal), the HGH response to hypoglycaemia normal, basal and TRH-stimulated thyroid function normal, and prolactin and its response to TRH normal when the patient was on steroid replacement, though elevated when she was steroid-deficient. The presenting symptom was weight loss.
The patient with TSH deficiency was asymptomatic. TSH levels (by radioimmunoassays employing different antisera and by cytochemical assay) were sometimes detectable, though total and free T4 and T3 levels were subnormal. There was subnormal TSH response to TRH injection on several occasions, and only a very small TSH response to twice-daily ingestion of TRH (40 mg twice daily by mouth) over three weeks. Gonadotrophins and their response to LHRH, growth hormone and cortisol and their response to hypoglycaemia, and prolactin and its response to TRH were all normal. This patient also had TBG deficiency. Autoantibodies directed against pituitary tissue were not detected in either case.
The defects may lie in the pituitary rather than the hypothalamus, because of the failure to respond to pituitary stimulation, but immunofluorescence and electron microscopic study of pituitary cells would give more conclusive information on the aetiology.
